Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Open-market sale Chief Executive Officer sold 12,094 shares at an average $82.40 ($996,521)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 295 shares (to pay taxes)
  3. 4/A Open-market sale Director sold 5,000 shares at an average $66.94 ($334,715)
  4. 4 Open-market sale Director sold 1,295 shares at $77.35 ($100,168)
  5. 4/A Derivatives Options or other derivatives
  6. 4/A Derivatives Options or other derivatives
  7. 4/A Derivatives Options or other derivatives
  8. 4 Open-market sale Director sold 5,000 shares at an average $66.94 ($334,715)
  9. 4 Grant or award Director acquired 923 shares (grant or award)
  10. 4 Grant or award Director acquired 923 shares (grant or award)
  11. 4 Grant or award Director acquired 1,292 shares (grant or award)
  12. 4 Grant or award Director acquired 923 shares (grant or award)
  13. 4 Grant or award Director acquired 923 shares (grant or award)
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 34 · 669 filings